Cell Therapeutics (CTIC)
Your Dashboard
Displaying CTIC Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 5.491M
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value 25.65M
- Book Value per Share 0.1132
- Capital Expenditures 0.214M
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing -0.087M
- Cash Financing TTM 40.04M
- Cash Investing -0.214M
- Cash Investing TTM -2.559M
- Cash Operations -18.99M
- Cash Operations TTM -54.85M
- Cash and Equivalents 27.38M
- Cash and ST Investments 27.38M
- Current Ratio 2.131
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.1592
- Dividend
- Dividend Yield 0.00%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share -0.09
- Earnings Per Share Growth
- Earnings Per Share TTM -0.45
- Earnings Yield -49.45%
- Effective Tax Rate TTM Pro
- Enterprise Value 182.92M
- Expenses
- Expenses TTM
- Free Cash Flow -19.21M
- Free Cash Flow TTM -57.41M
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense 0.055M
- Interest Income 0.24M
- Inventories
- KZ Index Pro
- Liabilities 18.50M
- Long Term Debt 4.083M
- Market Cap 206.22M
- Net Income -17.45M
- Net Income TTM -87.51M
- Net PP&E 4.261M
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price 0.91
- Price / Book Value 8.040
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense 8.17M
- Receivables Turnover
- Retained Earnings -1.732B
- Retained Earnings Growth
- Return on Assets -152.6%
- Return on Equity -354.3%
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense 9.928M
- Shareholders Equity 25.65M
- Shares Outstanding 226.61M
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 44.15M
- Total Return Price 0.91
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these CTIC related companies
CTIC News
CellTherapeutics (CTIC) Gets Conditional EC Marketing Authorization for Pixuvri
May 11, 9:14AM Street Insider
May 11, 9:14AM Street Insider
Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
Apr 20, 1:30AM PR Newswire
Apr 20, 1:30AM PR Newswire
Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Apr 19, 8:00PM PR Newswire
Apr 19, 8:00PM PR Newswire
Cell Therapeutics (CTIC) to Acquire Rights on S*BIO's Pacritinib JAK2 Inhibitor
Apr 19, 6:54AM Street Insider
Apr 19, 6:54AM Street Insider
Cell Therapeutics, Inc. (CTI) to Host Conference Call April 19, 8:30 AM ET
Apr 18, 8:00PM PR Newswire
Apr 18, 8:00PM PR Newswire
Cell Therapeutics and Keryx Biopharmaceuticals Hope for Help From the TREAT Act
Mar 22, 8:20AM Marketwire
Mar 22, 8:20AM Marketwire
Cell Therapeutics and Avanir Pharmaceuticals Look to Make Headway in Strengthening Biotech Industry
Mar 12, 8:20AM Marketwire
Mar 12, 8:20AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CTIC | 0.91 | -0.01 | -1.09% | 206.22M |
| CTHR | 3.89 | +0.03 | +0.78% | 75.66M |
| CTGX | 12.45 | +0.16 | +1.30% | 230.70M |
| CTFO | 4.55 | -0.09 | -1.94% | 114.98M |
| CTEL | 10.58 | -0.19 | -1.76% | 408.92M |
| CTCT | 20.58 | +0.12 | +0.59% | 622.13M |
| CTCM | 9.35 | -0.10 | -1.06% | 1.471B |
| CTB | 15.21 | -0.25 | -1.62% | 947.58M |
| CTAS | 37.31 | -0.41 | -1.09% | 4.840B |
| CSU | 9.67 | +0.12 | +1.26% | 272.11M |
